The TGFBR2 belongs to the serine/threonine protein kinase family and the TGF-β receptor subfamily, and cases of disrupted TGF-β pathway have been demonstrated to stimulate tumor progression [17]. The gene discussed is TGFBR2; the disease is neoplasm.